MEI Pharma Inc (MEIP)
2.90
-0.11
(-3.65%)
USD |
NASDAQ |
Nov 15, 11:20
MEI Pharma Net Income (TTM): 17.78M for June 30, 2024
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2024 | 17.78M |
| March 31, 2024 | 26.16M |
| December 31, 2023 | 19.84M |
| September 30, 2023 | 41.16M |
| June 30, 2023 | -31.84M |
| March 31, 2023 | -37.87M |
| December 31, 2022 | -31.16M |
| September 30, 2022 | -53.57M |
| June 30, 2022 | -54.45M |
| March 31, 2022 | -46.77M |
| December 31, 2021 | -63.67M |
| September 30, 2021 | -59.54M |
| June 30, 2021 | -41.31M |
| March 31, 2021 | -52.57M |
| December 31, 2020 | -31.28M |
| September 30, 2020 | -43.47M |
| June 30, 2020 | -47.17M |
| March 31, 2020 | -24.49M |
| December 31, 2019 | -37.51M |
| September 30, 2019 | -5.271M |
| June 30, 2019 | -16.82M |
| March 31, 2019 | -39.12M |
| December 31, 2018 | -27.72M |
| September 30, 2018 | -45.82M |
| June 30, 2018 | -40.07M |
| Date | Value |
|---|---|
| March 31, 2018 | -25.16M |
| December 31, 2017 | -19.81M |
| September 30, 2017 | -1.848M |
| June 30, 2017 | 2.67M |
| March 31, 2017 | 1.243M |
| December 31, 2016 | -3.526M |
| September 30, 2016 | -20.51M |
| June 30, 2016 | -20.86M |
| March 31, 2016 | -20.75M |
| December 31, 2015 | -24.31M |
| September 30, 2015 | -28.32M |
| June 30, 2015 | -32.69M |
| March 31, 2015 | -35.57M |
| December 31, 2014 | -34.03M |
| September 30, 2014 | -31.24M |
| June 30, 2014 | -27.15M |
| March 31, 2014 | -21.82M |
| December 31, 2013 | -17.19M |
| September 30, 2013 | -13.62M |
| June 30, 2013 | -11.19M |
| March 31, 2013 | -10.07M |
| December 31, 2012 | -9.588M |
| September 30, 2012 | -8.375M |
| June 30, 2012 | -7.523M |
| March 31, 2012 | -7.064M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-63.67M
Minimum
Dec 2021
41.16M
Maximum
Sep 2023
-29.04M
Average
-37.87M
Median
Mar 2023
Net Income (TTM) Benchmarks
| Avid Bioservices Inc | -144.16M |
| Evoke Pharma Inc | -6.147M |
| Revance Therapeutics Inc | -184.44M |
| NovaBay Pharmaceuticals Inc | -10.12M |
| Palatin Technologies Inc | -30.42M |